日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Preoperative Immune-Related Adverse Events in Resectable NSCLC Treated With Neoadjuvant Nivolumab Plus Chemotherapy: A Multicenter Retrospective Analysis

接受新辅助纳武利尤单抗联合化疗的可切除非小细胞肺癌患者术前免疫相关不良事件:一项多中心回顾性分析

Watanabe, Takuya; Nomura, Kotaro; Takamori, Shinkichi; Tane, Shinya; Ohara, Shuta; Oiki, Hana; Katsumata, Shinya; Endo, Makoto; Takamori, Satoshi; Nakatsuka, Marina; Tenpaku, Hironori; Nakamura, Ryuji; Notsuda, Hirotsugu; Namba, Kei; Minegishi, Kentaro; Tanahashi, Masayuki; Tsuboi, Masahiro; Soh, Junichi; Shimokawa, Mototsugu; Ohde, Yasuhisa

Advances in Lung Cancer Basic and Translational Research in 2025 - Overview and Perspectives Focusing on NSCLC

2025年肺癌基础和转化研究进展——概述与展望(聚焦非小细胞肺癌)

Mascaux, Celine; Sen, Triparna; Sanchez-Cespedes, Montse; Ortiz-Cuaran, Sandra; Bossé, Yohan; Dammeijer, Floris; Cavic, Milena; Barr, Martin P; Arulananda, Surein; Armisen, Ricardo; Berger, Alice H; Bianchi, Fabrizio; Carbone, David P; Cerciello, Ferdinando; Lockwood, William W; Mitsudomi, Tetsuya; Ohara, Shuta; Politi, Katerina; Qin, Sida; Roisman, Laila C; Samstein, Robert; Skoulidis, Ferdinandos; Tan, Aaron C; Thomas, Anish; Zhang, Jianjun; Wynes, Murry W; John, Thomas; Tsao, Ming Sound

Efficacy of Conventional and Novel Tyrosine Kinase Inhibitors for Uncommon EGFR Mutations-An In Vitro Study

传统和新型酪氨酸激酶抑制剂对罕见EGFR突变的疗效——一项体外研究

Oiki, Hana; Suda, Kenichi; Hamada, Akira; Fujino, Toshio; Obata, Keiko; Kobayashi, Yoshihisa; Sakai, Kazuko; Fukuda, Shota; Ohara, Shuta; Ito, Masaoki; Soh, Junichi; Nishio, Kazuto; Mitsudomi, Tetsuya; Tsutani, Yasuhiro

Utility and Future Perspectives of Circulating Tumor DNA Analysis in Non-Small Cell Lung Cancer Patients in the Era of Perioperative Chemo-Immunotherapy

循环肿瘤DNA分析在围手术期化疗免疫治疗时代非小细胞肺癌患者中的应用及未来展望

Ohara, Shuta; Suda, Kenichi; Tsutani, Yasuhiro

Refining Surgical Standards: The Role of Robotic-Assisted Segmentectomy in Early-Stage Non-Small-Cell Lung Cancer

完善手术标准:机器人辅助肺段切除术在早期非小细胞肺癌中的作用

Nishino, Masaya; Ujiie, Hideki; Ito, Masaoki; Oiki, Hana; Fukuda, Shota; Nishina, Mai; Ohara, Shuta; Hamada, Akira; Chiba, Masato; Takemoto, Toshiki; Tsutani, Yasuhiro

Clinical Significance of Perioperative Minimal Residual Disease Detected by Circulating Tumor DNA in Patients With Lung Cancer With a Long Follow-up Data: An Exploratory Study

循环肿瘤DNA检测围手术期微小残留病灶在肺癌患者长期随访中的临床意义:一项探索性研究

Ohara, Shuta; Suda, Kenichi; Sudhaman, Sumedha; Hamada, Akira; Chiba, Masato; Shimoji, Masaki; Takemoto, Toshiki; Kalashnikova, Ekaterina; Cheung, Samantha K; Krainock, Michael; Feeney, Jordan; Sethi, Himanshu; Liu, Minetta C; Soh, Junichi; Tsutani, Yasuhiro; Mitsudomi, Tetsuya

Low OLFM1 and BMP6 Expression Predicts Recurrence in Early-Stage Nonsquamous NSCLC with Pure Solid Tumor Appearance.

OLFM1 和 BMP6 低表达预示着早期非鳞状 NSCLC 纯实体瘤样表现的复发。

Suda Kenichi, Yoshida Yukihiro, Sato Hidenori, Ohara Shuta, Hamada Akira, Yotsukura Masaya, Shiraishi Kouya, Hamamoto Ryuji, Chiba Yasutaka, Kohno Takashi, Yatabe Yasushi, Watanabe Shun-Ichi, Tsutani Yasuhiro, Mitsudomi Tetsuya

Improved platelet separation performance from whole blood using an acoustic fluidics system

利用声学流体系统提高全血中血小板分离性能

Sakai, Kazuko; Ohara, Shuta; Tanaka, Junko; Suda, Kenichi; Muramatsu, Takamichi; Uematsu, Chihiro; Tsutani, Yasuhiro; Mitsudomi, Tetsuya; Nishio, Kazuto

Clinical factors associated with high PD-L1 expression in patients with early-stage non-small cell lung cancer

早期非小细胞肺癌患者中与PD-L1高表达相关的临床因素

Ohara, Shuta; Suda, Kenichi; Hamada, Akira; Chiba, Masato; Ito, Masaoki; Shimoji, Masaki; Takemoto, Toshiki; Soh, Junichi; Tsutani, Yasuhiro

Bioinformatics analysis reveals SOD1 is a prognostic factor in lung adenocarcinoma.

生物信息学分析表明,SOD1 是肺腺癌的预后因素

Gao Ling, Wang Wei, Ma Haishan, Yin Minghui, Yang Xuejiao, Han Ruihui, Ohara Shuta, Kim Dohun, Wang Guangyan